| Authors: |
Hatch CC; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Brookline Ave, Boston, MA, 02215, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Levy LH; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Brookline Ave, Boston, MA, 02215, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Kelly KM; Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Division of Pediatric Hematology/Oncology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA., Revette A; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Krieger M; Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Moynihan L; Division of Pediatric Hematology/Oncology, Hasbro Children's Hospital, Providence, RI, USA., Carter N; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Brookline Ave, Boston, MA, 02215, USA., Selig R; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Brookline Ave, Boston, MA, 02215, USA., Vrooman LM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Brookline Ave, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA., Kahn JM; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA., Greenzang KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Brookline Ave, Boston, MA, 02215, USA. katie_greenzang@dfci.harvard.edu.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA. katie_greenzang@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. katie_greenzang@dfci.harvard.edu. |
